| Name | tert-butyl 5-methoxy-2-oxospiro[1H-indole-3,4'-piperidine]-1'-carboxylate |
|---|---|
| Synonyms |
tert-Butyl 5-methoxy-2-oxo-1,2-dihydro-1'H-spiro[indole-3,4'-piperidine]-1'-carboxylate
Spiro[3H-indole-3,4'-piperidine]-1'-carboxylic acid, 1,2-dihydro-5-methoxy-2-oxo-, 1,1-dimethylethyl ester 2-Methyl-2-propanyl 5-methoxy-2-oxo-1,2-dihydro-1'H-spiro[indole-3,4'-piperidine]-1'-carboxylate |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 512.4±50.0 °C at 760 mmHg |
| Molecular Formula | C18H24N2O4 |
| Molecular Weight | 332.394 |
| Flash Point | 263.7±30.1 °C |
| Exact Mass | 332.173615 |
| PSA | 67.87000 |
| LogP | 2.70 |
| Vapour Pressure | 0.0±1.3 mmHg at 25°C |
| Index of Refraction | 1.579 |
| Storage condition | 2-8°C |
| Hazard Codes | Xi |
|---|
|
~69%
752234-64-3 |
| Literature: NOVARTIS AG; NOVARTIS PHARMA GMBH Patent: WO2004/76455 A1, 2004 ; Location in patent: Page 26; 27 ; WO 2004/076455 A1 |
|
~%
752234-64-3 |
| Literature: WO2004/76455 A1, ; Page 26 ; WO 2004/076455 A1 |
|
~%
752234-64-3 |
| Literature: WO2004/69256 A1, ; Page/Page column 46 ; WO 2004/069256 A1 |
| Precursor 4 | |
|---|---|
| DownStream 0 | |